Latest News and Press Releases

aavantgarde_logo.jpg
AAVantgarde Bio Announces FDA Orphan Drug Designation for AAVB-081 for the Treatment of Usher Syndrome Type 1B Retinitis Pigmentosa
December 02, 2024 02:00 ET | AAVantgarde Bio
AAVantgarde Bio Announces FDA Orphan Drug Designation for AAVB-081 for the Treatment of Usher Syndrome Type 1B Retinitis Pigmentosa
Annual General Meeti
Annual General Meeting to approve the 2023 financial statements to be held on January 31, 2025 at 10:00am CET at the Company’s headquarters
December 02, 2024 02:00 ET | Atos International
Press Release Annual General Meeting to approve the 2023 financial statements to be held on January 31, 2025 at 10:00am CET at the Company’s headquarters Paris, France – December 2, 2024 – Following...
sequana_rgb_300.png
Press Release: Sequana Medical announces update on second tranche of convertible bridge loan
December 02, 2024 02:00 ET | Sequana Medical NV
SEQUANA MEDICAL ANNOUNCES UPDATE ON SECOND TRANCHE OF CONVERTIBLE BRIDGE LOAN Ghent, Belgium – 2 December 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a...
Anoto_logo.jpg
Updated first day of trading in BTAs and subscriptions rights
December 02, 2024 02:00 ET | Anoto Group AB
Anoto Group AB (the "Company" or “Anoto”) today announces that the Company's board of directors has decided to update the first day of trading in BTAs (paid subscribed shares) and subscriptions rights...
01-Logotipo.png
deepull receives FDA Breakthrough Device Designation for its UllCORE Bloodstream Infection Test
December 02, 2024 02:00 ET | DeepUll
deepull receives FDA Breakthrough Device Designation for its UllCORE Bloodstream Infection Test Barcelona, Spain – 2 December 2024 – deepull, a medical diagnostics company developing culture-free...
ICG Enterprise Trust Logo for GNW.png
Voting Rights and Capital
December 02, 2024 02:00 ET | ICG Enterprise Trust Plc
ICG Enterprise Trust plc (the “Company”) 2 December 2024 Total Voting Rights In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1R, the Company announces as follows. At the...
ICG.png
Intermediate Capital Group plc :
December 02, 2024 02:00 ET | Intermediate Capital Group plc
Intermediate Capital Group plc (the “Company”) 2 December 2024 Total Voting Rights In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1R, the Company announces as follows. ...
Subsea7 share repurchases
December 02, 2024 02:00 ET | Subsea 7 (Uk Service Co) Ltd
Luxembourg – 2 December 2024 - Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced transactions made in accordance with its share repurchase programme during the week commencing 25 November...
Total Voting Rights and Capital
December 02, 2024 02:00 ET | OCTOPUS FUTURE GENERATIONS VCT PLC
Octopus Future Generations VCT plc Total Voting Rights and Capital Octopus Future Generations VCT plc (‘the Company’) announces that as at 30 November 2024 its issued share capital consists of...
Total Voting Rights and Capital
December 02, 2024 02:00 ET | Octopus AIM VCT PLC
Octopus AIM VCT plc Total Voting Rights and Capital Octopus AIM VCT plc (‘the Company’) announces that as at 30 November 2024 its issued share capital consists of 216,493,257 Ordinary shares of 1p...
12...293408
Next Page keyboard_arrow_right